Stroke Risk With Oral Contraceptives in Setting of Concurrent High-Risk Conditions

Stroke 2014 Jan 21;[EPub Ahead of Print], KA Ryan, JW Cole, K Saslow, BD Mitchell, PF McArdle, MJ Sparks, YC Cheng, SJ Kittner
Consensus and Guidelines · January 28, 2014

Full Story
Journal Reference

TAKE-HOME MESSAGE

  • This study looked at 572 women, aged 15 to 49 years, who were taking oral contraceptives (OCs). Of these, 256 reported being advised against OC use by their physician because of stroke-risk modifiers. However, 24% of these women continued to use OCs, and only 15% remembered being advised not to take them. Overall, OC was significantly associated with stroke (OR, 2.00), particularly in those advised by their physician not to take them due to stroke risk (OR, 3.12). Smoking and headache were the two most common reasons cited for not taking OCs, and both were significantly associated with stroke (OR, 4.29 and 3.82, respectively) in women advised against OC use.
  • The results confirm that increased risk of stroke occurs among women taking OCs who have certain medical conditions as well as the importance of compliance with physician counseling by these patients.

ABSTRACT

BACKGROUND AND PURPOSE

Literature suggests a small increased risk of ischemic stroke with oral contraception (OC) use. We evaluated the association of stroke and OC use in women on the basis of whether they recalled being advised by a physician not to use OC or to discontinue OC use because of the presence of stroke risk modifiers, and whether such advice resulted in behavioral change.

METHODS

A total of 572 women (224 strokes and 348 controls) aged 15 to 49 years were interviewed about OC use and risk modifiers, including cigarette smoking and headaches, among others.

RESULTS

The adjusted odds ratio for OC use and stroke was 2.00 (95% confidence interval, 1.29-3.09). The association of OC use with stroke was stronger in women that reported receiving doctor’s advice against OC use because of the presence of other stroke risk modifiers (odds ratio, 3.12; 95% confidence interval, 1.62-6.00) than in women who did not recall receiving such advice (odds ratio, 1.31; 95%confidence interval, 0.71-2.43). Of 256 women who recalled being advised by their doctor not to start OC or to discontinue OC use because of the presence of other stroke risk modifiers, 24% were still on OC at the time of stroke or interview.

CONCLUSIONS

We confirm that certain medical conditions increase the risk of stroke during OC use and demonstrate the importance of physician counseling in those using OC in the setting of concurrent high-risk conditions and the need for improved patient compliance with such counseling.


Stroke; A Journal of Cerebral Circulation

Prevention Opportunities for Oral Contraceptive–Associated Ischemic Stroke

Stroke 2014 Jan 21;[EPub Ahead of Print], KA Ryan, JW Cole, K Saslow, BD Mitchell, PF McArdle, MJ Sparks, YC Cheng, SJ Kittner

Full Story
Journal Reference

Comments Are Closed